BANGKOK, Dec 15 (TNA) – Thailand is due to start its Influenza A(H1N1) nasal spray vaccine trials on the first group of volunteers this Friday, according to Dr Vichai Chokewiwat, chair of the Government Pharmaceutical Organisation (GPO).
The vaccine trial for humans is ready after the problem of the vaccine’s stability was solved.
The nasal spray H1N1 vaccine trials will begin on 24 volunteers on Friday. The test volunteers will stay at hospital for one week to ensure the vaccine has no side affects such as headache or vomiting.
After that segment, the trials will be extended to cover 400 volunteers before evaluation will be conducted.
Meanwhile, imported Influenza A(H1N1) vaccines from overseas will arrive in Thailand next week and will be kept at the pharmaceutical organisation’s headquarters before being turned over to the public health ministry for injection in high risk groups such as pregnant women and health officials.